Success Stories: Iranian Professor and Education Dean Earns NIW Approval for Advancing Life-Saving Cardiovascular Procedures

Posted by wegreened on January 30, 2026 in Medical (Gastroenterology, Cancer, Cancer Pharmacology, Cardiology, Immunology, Pathology, Hematology, Neurology, Neuroscience, Urology, Gynecology, Dentistry, Endocrinology), NIW

Client’s Testimonial:

“Thank you for ensuring everything is in order. I appreciate your guidance.”

On January 27^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Professor and Education Dean in the field of Interventional Cardiology (Approval Notice).

General Field: Interventional Cardiology

Position at the Time of Case Filing: Professor and Education Dean

Country of Origin: Iran

Country of Residence at the Time of Filing: Iran

Approval Notice Date: January 27^th, 2025

Processing Time: 9 months, 17 days

Case Summary:

We are pleased to share the NIW approval of a professor and education dean from Iran. At the time of filing, the client was conducting research to improve interventional techniques for coronary, congenital, and structural heart diseases. His work aims to make cardiovascular treatments safer, more efficient, and minimally invasive. Supported by a strong publication record, hundreds of citations, and expert endorsements, he presented a compelling case for NIW approval.

Research with Substantial Merit and National Importance

The client’s research enhances interventional cardiology by developing novel stent designs, optimizing percutaneous coronary interventions (PCI), and advancing minimally invasive heart repair. Cardiovascular diseases remain a leading cause of death and economic loss in the U.S., and his work directly supports national efforts to improve cardiac care, reduce costs, and enhance treatment access.

Academic Achievements and Recognition

The client holds an M.D. and has authored 117 peer-reviewed journal articles (26 first-authored) and 4 book chapters (3 first-authored), with 703 citations from independent researchers. His studies in top journals such as JACC: Cardiovascular Interventions and European Journal of Heart Failure have shaped clinical practice worldwide. Several of his papers rank among the top 10–20% most cited in clinical medicine, demonstrating the sustained impact of his findings.

Expert Endorsements

Independent experts praised the originality and national relevance of his work.

One recommender wrote:

“He is and will be an asset to any institution engaging in interventional cardiology research. The United States has a vested interest in this field of study, and [client]’s research outcomes would greatly benefit the country’s healthcare system.”

This testimony underscores both the innovation and clinical significance of his contributions.

NIW Approval and Outlook

The I-140 NIW petition was filed on April 10, 2024, and approved on January 27, 2025. With NAILG’s support, the client successfully demonstrated the national importance of his work and his capacity to advance U.S. healthcare goals. His ongoing research will continue to improve interventional cardiology techniques and strengthen the nation’s ability to treat complex cardiac diseases.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)

Category	Approval or Refund^®		Approval or Refiling^TM
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	28,946	99.52%	3,030	98.31%
EB1A	4,322	91.76%	2,870	88.91%
EB1B	793	98.51%	236	90.77%
Total	34,061	98.44%	6,136	93.39%